Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA

Theravance Biopharma (TBPH) Will Make VIBATIV Poster Presentation at ATS 2016May 11, 2016 8:06 AM Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)May 9, 2016 8:05 AM